Our Pipeline
EDI advances high-potential, preclinical-stage therapeutics across multiple therapeutic areas through a unique academic-industry collaboration model. Our portfolio is built on scientific excellence and translational rigor.
Pipeline Snapshot
* Interactive popup links are only supported on desktop devices. These features will not work on mobile or tablet.
Asset
Indication
Modality
Investigator
Target Val. Opt.
Target-to-Hit
Hit-to-Lead
Lead Opt.
Immunotherapy Platform
Platform
Sathy Balu, PhD
Wound Healing
Peptide
Denise Hocking, PhD
Hemophilia A
Circular RNA
Doug Anderson, PhD
Oncology
Small Molecule
Rakesh Singh, PhD
Cystic Fibrosis, Cough
Small Molecule
Bing Gong, PhD
DKD
Peptide
Joan Krepinsky, MD
Obesity
siRNA
Greg Steinberg, PhD
EDI-L217*
Type 1 Diabetes
ASO
Chris Holley MD, PhD
Oncology
Small Molecule
David Heppner, PhD
EDI-L219*
Type 2 Diabetes
Small Molecule
Julien Sebag, PhD
Mitochondria Energy Platform
Oligo, ASO
Anna Blumental, PhD
For more information,
Our Values
1. Innovation
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla facilisi. Fusce varius, arcu et faucibus tincidunt, nunc sapien volutpat tortor, eget dapibus odio odio in justo.
2. Collaboration
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla facilisi. Fusce varius, arcu et faucibus tincidunt, nunc sapien volutpat tortor, eget dapibus odio odio in justo.
3. impact
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla facilisi. Fusce varius, arcu et faucibus tincidunt, nunc sapien volutpat tortor, eget dapibus odio odio in justo.
What We Do
Target to hit
HIT TO LEAD
Lead Optimization
Pre-Clinical
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla facilisi. Fusce varius, arcu et faucibus tincidunt, nunc sapien volutpat tortor, eget dapibus odio odio in justo. Sed eget massa eu augue sodales sodales. Suspendisse potenti.
Donec sagittis eros et velit fermentum, at tincidunt felis bibendum. Etiam in orci et ligula tincidunt tincidunt. Duis posuere, libero vel malesuada consequat, felis eros cursus eros, non cursus nisi arcu vel risus.